Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours.
Tumour-associated lymphatics contribute to a key component of metastatic spread, however, the biological interaction of tumour cells with intratumoural and peritumoural lymphatics (ITLs and PTLs) has remained unclear. To address this important issue, we have focused on the morphological and molecular aspects of newly formed lymphatics (lymphangiogenesis) and pre-existing lymphatics in the intratumoural and peritumoural tissues by using a hybridoma-induced tumour model. In the present study, ITLs with very high vessel density within the tumour mass showed small and flattened contours that varied from non-solid-to-solid tumours, whereas PTLs were relatively disorganized and tortuous, and packed with a cluster of tumour cells at the tumour periphery. Lymphatic endothelial cells (LECs) both in ITLs and PTLs were expressed with LYVE-1 and podoplanin in various tumour tissues, in which initial lymphatics were extremely extended and dilated. The tumour cells were frequently detected adhering to or penetrating lymphatic walls, especially near the open junctions. In the metastatic tissues, lymphangiogenic vasculatures occurred within the tumour matrix, and collecting PTLs represented abnormal twisty valve leaflets. The Western blot and RT-PCR analysis showed local variations of LEC proliferating potentials and lymphatic involvement in metastasis by a distinct profile of the protein and mRNA expression by LYVE-1, podoplanin, Prox-1 and vascular endothelial growth factor-3 (VEGFR-3). These findings indicated that both ITLs and PTLs, including enlarged pre-existing and newly formed lymphatics, may play a crucial role in metastasis with an active tumour cell adhesion, invasion, migration and implantation.
Ji
R C
RC
Department of Anatomy, Biology and Medicine, Oita University Faculty of Medicine, Oita, Japan. ji@med.oita-u.ac.jp
Eshita
Y
Y
Kato
S
S
D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D004729:Endothelium, Lymphatic / Q000378:metabolism / Q000473:pathology; D006023:Glycoproteins / Q000378:metabolism*; D018398:Homeodomain Proteins / Q000378:metabolism; D042583:Lymphangiogenesis; D042601:Lymphatic Vessels / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D008562:Membrane Glycoproteins / Q000378:metabolism*; D026901:Membrane Transport Proteins; D051379:Mice; D008807:Mice, Inbred BALB C; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D025521:Tumor Suppressor Proteins / Q000378:metabolism; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000378:metabolism; D000098551:Prospero-Related Homeobox 1 Protein; D000098853:Podoplanin
D015415:Biomarkers; D006023:Glycoproteins; D018398:Homeodomain Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009363:Neoplasm Proteins; D025521:Tumor Suppressor Proteins; D040321:Vascular Endothelial Growth Factor Receptor-3; D000098551:Prospero-Related Homeobox 1 Protein; C490441:Pdpn protein, mouse; D000098853:Podoplanin; C492273:LYVE1 protein, mouse
EMBO J. 2001 Feb 15;20(4):672-82
11179212
Cancer Metastasis Rev. 2006 Dec;25(4):677-94
17160713
Nat Med. 2001 Feb;7(2):192-8
11175850
Nature. 2001 Mar 1;410(6824):50-6
11242036
EMBO J. 2001 Mar 15;20(6):1223-31
11250889
Cancer Res. 2001 Nov 15;61(22):8079-84
11719431
Cancer Res. 2002 Mar 1;62(5):1315-20
11888898
J Natl Cancer Inst. 2002 Mar 20;94(6):417-21
11904313
Mod Pathol. 2002 Apr;15(4):434-40
11950918
Science. 2002 Jun 7;296(5574):1883-6
11976409
Cancer Cell. 2002 Apr;1(3):219-27
12086857
Mech Dev. 2002 Oct;118(1-2):147-55
12351178
J Exp Med. 2002 Dec 2;196(11):1497-506
12461084
Clin Cancer Res. 2003 Jan;9(1):250-6
12538477
J Pathol. 2003 Jun;200(2):195-206
12754740
Am J Pathol. 2003 Jun;162(6):1951-60
12759251
Lab Invest. 2003 Nov;83(11):1681-3
14615421
Cancer Res. 2003 Dec 1;63(23):8221-5
14678978
Eur J Cancer. 2004 Feb;40(3):358-64
14746853
Kidney Int. 2004 Jul;66(1):91-101
15200416
Cancer Res. 2004 Jul 1;64(13):4400-4
15231646
Br J Cancer. 1996 Dec;74(12):2003-7
8980404
Science. 1997 May 30;276(5317):1423-5
9162011
Cancer Res. 1998 Apr 15;58(8):1599-604
9563467
Exp Cell Res. 1999 Feb 1;246(2):368-75
9925752
Am J Pathol. 1999 Feb;154(2):385-94
10027397
Histol Histopathol. 2005 Jan;20(1):155-75
15578435
Cancer Cell. 2005 Feb;7(2):121-7
15710325
Hum Pathol. 2005 Apr;36(4):372-80
15891998
Blood. 2005 Jun 15;105(12):4649-56
15705793
Acta Neuropathol. 2005 May;109(5):497-502
15864611
Cancer Res. 2005 Oct 15;65(20):9261-8
16230387
Nature. 2005 Dec 15;438(7070):946-53
16355212
Lymphat Res Biol. 2006;4(2):83-100
16808670
Anat Sci Int. 2006 Dec;81(4):201-9
17176958
Nat Med. 2001 Feb;7(2):186-91
11175849